Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Tracon Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 21 | 24 | +3 |
| Shares | 9.31M | 5.16M | −4.15M (−44.6%) |
| Value | $1.66M | $903.4K | −$754.3K (−45.5%) |
New holders (7)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 412,271 | $72.2K | 0.00% |
| Acadian Asset Management LLC | 413,909 | $72.0K | 0.00% |
| Millennium Management LLC | 191,453 | $33.5K | 0.00% |
| GTS Securities LLC | 15,794 | $2.76K | 0.00% |
| Game Plan Financial Advisors, LLC | 1,000 | $175 | 0.00% |
| Qube Research & Technologies Ltd | 800 | $140 | 0.00% |
| Morgan Stanley | 200 | $35 | 0.00% |
Sold out (4)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $848.1K |
| Susquehanna International Group, LLP | 15,835 | $2.82K |
| Group One Trading, L.P. | 311 | $55 |
| JPMorgan Chase & Co | 21 | $4 |